Free Trial
→ Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___ (From Behind the Markets) (Ad)tc pixel Free EXE Stock Alerts

Extendicare (EXE) Competitors

Extendicare logo
C$31.73 +1.02 (+3.32%)
As of 06/3/2026 04:25 PM Eastern
Compare

EXE vs. SIA, DNTL, WELL, DR, and NLH

Should you buy Extendicare stock or one of its competitors? MarketBeat compares Extendicare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Extendicare include Sienna Senior Living (SIA), dentalcorp (DNTL), WELL Health Technologies (WELL), Medical Facilities (DR), and Nova Leap Health (NLH). These companies are all part of the "medical care facilities" industry.

How does Extendicare compare to Sienna Senior Living?

Sienna Senior Living (TSE:SIA) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Sienna Senior Living currently has a consensus price target of C$26.09, indicating a potential upside of 24.18%. Extendicare has a consensus price target of C$32.56, indicating a potential upside of 2.60%. Given Sienna Senior Living's higher probable upside, equities analysts clearly believe Sienna Senior Living is more favorable than Extendicare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sienna Senior Living
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.00
Extendicare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25

Sienna Senior Living has a beta of 0.95207, indicating that its share price is 5% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, indicating that its share price is 27% more volatile than the broader market.

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sienna Senior LivingC$1.05B2.13C$33.51MC$0.4843.77
ExtendicareC$1.75B1.72C$65.46MC$1.3623.35

Extendicare has a net margin of 6.99% compared to Sienna Senior Living's net margin of 4.34%. Extendicare's return on equity of 45.35% beat Sienna Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Sienna Senior Living4.34% 6.44% 3.58%
Extendicare 6.99%45.35%7.16%

Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.5%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.6%. Sienna Senior Living pays out 195.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Extendicare pays out 37.2% of its earnings in the form of a dividend.

26.2% of Sienna Senior Living shares are owned by institutional investors. Comparatively, 20.3% of Extendicare shares are owned by institutional investors. 0.1% of Sienna Senior Living shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Sienna Senior Living had 2 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for Sienna Senior Living and 0 mentions for Extendicare. Extendicare's average media sentiment score of 1.00 beat Sienna Senior Living's score of 0.50 indicating that Extendicare is being referred to more favorably in the news media.

Company Overall Sentiment
Sienna Senior Living Positive
Extendicare Positive

Summary

Extendicare beats Sienna Senior Living on 12 of the 19 factors compared between the two stocks.

How does Extendicare compare to dentalcorp?

dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

dentalcorp pays an annual dividend of C$0.08 per share and has a dividend yield of 0.7%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.6%. dentalcorp pays out -53.6% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
dentalcorpC$1.66B1.32-C$80.68M-C$0.14N/A
ExtendicareC$1.75B1.72C$65.46MC$1.3623.35

dentalcorp has a beta of 1.469634, meaning that its share price is 47% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, meaning that its share price is 27% more volatile than the broader market.

dentalcorp presently has a consensus target price of C$11.00, indicating a potential upside of 0.00%. Extendicare has a consensus target price of C$32.56, indicating a potential upside of 2.60%. Given Extendicare's stronger consensus rating and higher possible upside, analysts clearly believe Extendicare is more favorable than dentalcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
dentalcorp
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80
Extendicare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25

Extendicare has a net margin of 6.99% compared to dentalcorp's net margin of -1.64%. Extendicare's return on equity of 45.35% beat dentalcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
dentalcorp-1.64% -1.54% 0.77%
Extendicare 6.99%45.35%7.16%

17.9% of dentalcorp shares are held by institutional investors. Comparatively, 20.3% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Extendicare's average media sentiment score of 1.00 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company Overall Sentiment
dentalcorp Neutral
Extendicare Positive

Summary

Extendicare beats dentalcorp on 16 of the 18 factors compared between the two stocks.

How does Extendicare compare to WELL Health Technologies?

Extendicare (TSE:EXE) and WELL Health Technologies (TSE:WELL) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, WELL Health Technologies had 2 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for WELL Health Technologies and 0 mentions for Extendicare. Extendicare's average media sentiment score of 1.00 equaled WELL Health Technologies'average media sentiment score.

Company Overall Sentiment
Extendicare Positive
WELL Health Technologies Positive

WELL Health Technologies has lower revenue, but higher earnings than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareC$1.75B1.72C$65.46MC$1.3623.35
WELL Health TechnologiesC$1.47B0.84C$73.76MC$0.1143.91

Extendicare currently has a consensus price target of C$32.56, indicating a potential upside of 2.60%. WELL Health Technologies has a consensus price target of C$6.92, indicating a potential upside of 43.20%. Given WELL Health Technologies' higher possible upside, analysts clearly believe WELL Health Technologies is more favorable than Extendicare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Extendicare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

20.3% of Extendicare shares are owned by institutional investors. Comparatively, 5.0% of WELL Health Technologies shares are owned by institutional investors. 13.9% of Extendicare shares are owned by insiders. Comparatively, 6.8% of WELL Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Extendicare has a net margin of 6.99% compared to WELL Health Technologies' net margin of 1.82%. Extendicare's return on equity of 45.35% beat WELL Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Extendicare6.99% 45.35% 7.16%
WELL Health Technologies 1.82%3.15%2.07%

Extendicare has a beta of 1.273223, indicating that its stock price is 27% more volatile than the broader market. Comparatively, WELL Health Technologies has a beta of 0.865672, indicating that its stock price is 13% less volatile than the broader market.

Summary

Extendicare beats WELL Health Technologies on 12 of the 16 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Extendicare (TSE:EXE) and Medical Facilities (TSE:DR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

In the previous week, Medical Facilities had 1 more articles in the media than Extendicare. MarketBeat recorded 1 mentions for Medical Facilities and 0 mentions for Extendicare. Extendicare's average media sentiment score of 1.00 beat Medical Facilities' score of 0.00 indicating that Extendicare is being referred to more favorably in the media.

Company Overall Sentiment
Extendicare Positive
Medical Facilities Neutral

20.3% of Extendicare shares are held by institutional investors. Comparatively, 15.1% of Medical Facilities shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 0.4% of Medical Facilities shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Medical Facilities has a net margin of 8.51% compared to Extendicare's net margin of 6.99%. Extendicare's return on equity of 45.35% beat Medical Facilities' return on equity.

Company Net Margins Return on Equity Return on Assets
Extendicare6.99% 45.35% 7.16%
Medical Facilities 8.51%31.06%13.60%

Extendicare presently has a consensus price target of C$32.56, suggesting a potential upside of 2.60%. Given Extendicare's stronger consensus rating and higher possible upside, analysts clearly believe Extendicare is more favorable than Medical Facilities.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Extendicare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Medical Facilities
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareC$1.75B1.72C$65.46MC$1.3623.35
Medical FacilitiesC$260.72M1.17C$17.17MC$1.948.99

Extendicare has a beta of 1.273223, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Medical Facilities has a beta of 0.566457, suggesting that its stock price is 43% less volatile than the broader market.

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.6%. Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.5%. Extendicare pays out 37.2% of its earnings in the form of a dividend. Medical Facilities pays out 13.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Extendicare beats Medical Facilities on 14 of the 19 factors compared between the two stocks.

How does Extendicare compare to Nova Leap Health?

Nova Leap Health (CVE:NLH) and Extendicare (TSE:EXE) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment.

In the previous week, Extendicare's average media sentiment score of 1.00 beat Nova Leap Health's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company Overall Sentiment
Nova Leap Health Neutral
Extendicare Positive

Extendicare has a consensus target price of C$32.56, suggesting a potential upside of 2.60%. Given Extendicare's stronger consensus rating and higher possible upside, analysts clearly believe Extendicare is more favorable than Nova Leap Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nova Leap Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Extendicare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25

Extendicare has a net margin of 6.99% compared to Nova Leap Health's net margin of 0.64%. Extendicare's return on equity of 45.35% beat Nova Leap Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Nova Leap Health0.64% 1.10% 2.77%
Extendicare 6.99%45.35%7.16%

Nova Leap Health has a beta of 2.444711, suggesting that its stock price is 144% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, suggesting that its stock price is 27% more volatile than the broader market.

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nova Leap HealthC$32.23M0.96-C$300.30KC$0.00118.33
ExtendicareC$1.75B1.72C$65.46MC$1.3623.35

0.0% of Nova Leap Health shares are held by institutional investors. Comparatively, 20.3% of Extendicare shares are held by institutional investors. 40.8% of Nova Leap Health shares are held by company insiders. Comparatively, 13.9% of Extendicare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Extendicare beats Nova Leap Health on 13 of the 16 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXE vs. The Competition

Export
MetricExtendicareMedical Care Facilities IndustryMedical SectorTSE Exchange
Market CapC$3.01BC$1.59BC$6.47BC$12.49B
Dividend Yield1.67%3.81%2.69%6.21%
P/E Ratio23.3512.3822.1737.57
Price / Sales1.7218.70520.7911.23
Price / Cash3.207.9041.3482.29
Price / Book7.701.729.844.59
Net IncomeC$65.46MC$63.03MC$3.57BC$299.09M
7 Day Performance-1.83%5.50%-2.46%0.12%
1 Month PerformanceN/AN/AN/A17.05%
1 Year Performance120.19%10.09%26.49%51.19%

Extendicare Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXE
Extendicare
2.0821 of 5 stars		C$31.73
+3.3%		C$32.56
+2.6%		+119.4%C$3.01BC$1.75B23.3523,000
SIA
Sienna Senior Living
3.3692 of 5 stars		C$20.94
+0.4%		C$26.09
+24.6%		+13.1%C$2.21BC$1.05B43.6312,000
DNTL
dentalcorp
N/AC$11.00
+0.1%		C$11.00
+24.4%C$2.19BC$1.66BN/A9,950
WELL
WELL Health Technologies
2.8365 of 5 stars		C$4.88
+6.3%		C$6.25
+28.1%		+19.6%C$1.25BC$1.47B44.36510
DR
Medical Facilities
N/AC$17.49
+0.1%		N/A+13.5%C$306.60MC$260.72M9.021,833

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
A gold storm is coming – are you ready?
The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...
Traders Agency | Sponsoredtc pixel
The SpaceX S-1 changes everything
SpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...
Crypto 101 Media | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel